ramosetron has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
---|---|---|---|---|---|
194 | 94 | 83 | 40,215 | 1,423 | 9,631 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huh, J; Kim, HJ; Kim, KM; Lee, JM; Lee, SK; Park, EY | 1 |
1 trial(s) available for ramosetron and gamma-aminobutyric acid
Article | Year |
---|---|
Combination of gabapentin and ramosetron for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: a prospective randomized comparative study.
Topics: Adult; Amines; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, General; Antiemetics; Benzimidazoles; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Gynecologic Surgical Procedures; Humans; Laparoscopy; Middle Aged; Postoperative Nausea and Vomiting; Prospective Studies; Young Adult | 2017 |